This aligns with the STEP trial trajectory at the three-month mark
Rich in growth factors such as platelet-derived growth factor (PDGF), transforming growth factor- (TGF-), and insulin-like growth factor-1 (IGF-1), PRP may promote tissue repair and modulate synovial inflammation (Gato-Calvo et al., 2019)
In a phase 2 clinical trial targeting obese individuals without type 2 diabetes (T2D), retatrutide dosed at 1 to 12 mg resulted in up to 24.2% weight loss over a 48-week treatment period, compared to 2.1% in the placebo group, and demonstrated a dose-dependent effect
Gideon Heap Clarivate, London, UK
Through our weight loss treatment, youll get monthly medication plus one-to-one support from our clinicians and specialists, who will work with you to build habits that last